[CLDX] YoY Quarter Result on 30-Sep-2015 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
05-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- 1.17%
YoY- -13.88%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Revenue 941 3,924 2,220 1,026 1,101 980 3,113 -18.07%
PBT -7,243 -31,563 -29,598 -31,980 -28,082 -23,140 -15,027 -11.44%
Tax -14,912 -5,200 -790 -782 -2,260 -142 -105 128.32%
NP -7,243 -26,363 -29,598 -31,980 -28,082 -23,140 -15,027 -11.44%
Tax Rate - - - - - - - -
Total Cost 8,184 30,287 31,818 33,006 29,183 24,120 18,140 -12.41%
Ratio Analysis
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
NP Margin -769.71 -671.84 -1,333.24 -3,116.96 -2,550.59 -2,361.22 -482.72 8.08%
Per Share
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
EPS -0.66 -3.05 -4.41 -4.87 -4.71 -4.28 -3.79 -25.26%
EPS Diluted -0.66 -3.05 -4.41 -4.87 -4.71 -4.28 -3.79 -25.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.